PharmaJet will deliver two presentations on October 27 focusing on current and future applications of their needle-free technology. The Tropis® intradermal (ID) Needle-free Injection System overcomes ...
PharmaJet presentation will highlight the results of recent immunization studies using needle-free intradermal (ID) delivery for polio immunization campaigns. Data reinforces how increased coverage, ...
97% of healthcare workers preferred Tropis® ID for routine immunization. Vaccinators noted Tropis is easy to operate, resulted in less perceived child discomfort, and elicits a positive caregiver ...
Intradermal vaccination delivers antigen into the space between the epidermis and the dermis. This space is an anatomically favorable site for immune stimulation, enriched in a heterogenous population ...
The Monkeypox vaccine has just been given the green light by the Federal Drug Administration (FDA) to be administered via intradermal injection. This method will allow healthcare professionals to get ...
Injections deliver liquid medications, fluids, or nutrients directly into a person’s body. Different types of injections include intravenous, intramuscular, subcutaneous, intraosseous, and intradermal ...
Under the EUA, Jynneos can be administered either intradermally for individuals aged ≥18 years or subcutaneously for individuals aged The Food and Drug Administration (FDA) has granted emergency use ...
The U.S. is now allowing fractional doses of the Jynneos monkeypox vaccine to be administered via an injection that delivers the dose between, rather than under, layers of skin — an effort that will ...
The MarketWatch News Department was not involved in the creation of this content. -- Substantial Improvements in Coverage of IPV2 . Vaccine coverage of the second dose of inactivated polio vaccine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback